SciClone Pharmaceuticals (Holdings) Ltd
HKEX:6600
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
SciClone Pharmaceuticals (Holdings) Ltd
HKEX:6600
|
CN |
|
Superloop Ltd
ASX:SLC
|
AU |
|
A
|
Actinium Pharmaceuticals Inc
AMEX:ATNM
|
US |
|
Tritax Big Box Reit PLC
LSE:BBOX
|
UK |
|
K
|
Kraft Bank ASA
OSE:KRAB
|
NO |
|
I
|
IJM Corporation Bhd
KLSE:IJM
|
MY |
|
Deutsche Beteiligungs AG
XETRA:DBAN
|
DE |
|
Asia Potash International Investment Guangzhou Co Ltd
SZSE:000893
|
CN |
|
AnalytixInsight Inc
XTSX:ALY
|
CA |
|
Studio City International Holdings Ltd
NYSE:MSC
|
HK |
|
Xpro India Ltd
NSE:XPROINDIA
|
IN |
|
Bank KB Bukopin Tbk PT
IDX:BBKP
|
ID |
|
PetroChina Co Ltd
OTC:PCCYF
|
CN |
|
Mallee Resources Ltd
ASX:MYL
|
AU |
|
B
|
Blockchain Industries Inc
OTC:BCII
|
US |
|
H
|
HeliosX Lithium & Technologies Corp
XTSX:HX
|
CA |
|
E
|
Eva Precision Industrial Holdings Ltd
HKEX:838
|
HK |
|
BT Group PLC
XETRA:BTQ
|
UK |
|
T
|
Trevisa Investimentos SA
BOVESPA:LUXM4
|
BR |
|
C
|
Cheng Mei Materials Technology Corp
TWSE:4960
|
TW |
|
F
|
Flow Traders NV
LSE:0R96
|
NL |
|
B
|
Bank of Tianjin Co Ltd
HKEX:1578
|
CN |
|
SoFi Technologies Inc
NASDAQ:SOFI
|
US |
|
N
|
Nagarjuna Fertilizers and Chemicals Ltd
NSE:NAGAFERT
|
IN |
Wall Street
Price Targets
Price Targets Summary
SciClone Pharmaceuticals (Holdings) Ltd
According to Wall Street analysts, the average 1-year price target for SciClone Pharmaceuticals (Holdings) Ltd is 209.1 HKD with a low forecast of 207.05 HKD and a high forecast of 215.25 HKD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SciClone Pharmaceuticals (Holdings) Ltd's stock price target?
Price Target
209.1
HKD
According to Wall Street analysts, the average 1-year price target for SciClone Pharmaceuticals (Holdings) Ltd is 209.1 HKD with a low forecast of 207.05 HKD and a high forecast of 215.25 HKD.
What is SciClone Pharmaceuticals (Holdings) Ltd's Revenue forecast?
Projected CAGR
-1%
For the last 5 years the compound annual growth rate for SciClone Pharmaceuticals (Holdings) Ltd's revenue is 18%. The projected CAGR for the next 4 years is -1%.
What is SciClone Pharmaceuticals (Holdings) Ltd's Operating Income forecast?
Projected CAGR
-21%
For the last 5 years the compound annual growth rate for SciClone Pharmaceuticals (Holdings) Ltd's operating income is 19%. The projected CAGR for the next 4 years is -21%.
What is SciClone Pharmaceuticals (Holdings) Ltd's Net Income forecast?
Projected CAGR
-22%
For the last 5 years the compound annual growth rate for SciClone Pharmaceuticals (Holdings) Ltd's net income is 16%. The projected CAGR for the next 4 years is -22%.
